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Abstract
MicroRNAs (miRNAs) interact with 39 untranslated region (UTR) elements of target genes to regulate mRNA stability or
translation and thus play a role in regulating many different biological processes, including circadian rhythms. However,
specific miRNAs mediating the regulation of essential clock genes remain largely unknown. Because vesicles containing
membrane-bound miRNAs are present in the circulatory system, we examined miRNAs predicted to target the clock gene,
Bmal1, for evidence of rhythmic fluctuations in circulating levels and modulatory effects on the 39 UTR activity of Bmal1. A
number of miRNAs with Bmal1 as a predicted target were expressed in the serum of mice exposed to LD 12:12 and of these
miRNAs, miR-152 and miR-494 but not miR-142-3p were marked by diurnal oscillations with bimodal peaks in expression
occurring near the middle of the day and 8 or 12 hr later during the night. Co-transfection of pre-miR over-expression
constructs for miR-494 and miR-142-3p in HEK293 cells had significant effects in repressing luciferase-reported Bmal1 39 UTR
activity by as much as 60%, suggesting that these miRNAs may function as post-transcriptional modulators of Bmal1. In
conjunction with previous studies implicating miRNAs as extracellular regulatory signals, our results suggest that circulating
miRNAs may play a role in the regulation of the molecular clockworks in peripheral circadian oscillators.
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Introduction
MicroRNAs are small non-coding RNAs that have been
identified in many different organisms ranging from Drosophila to
humans [1] and implicated in the regulation of a wide array of
biological processes. Mature miRNAs are small RNA molecules,
typically 19–25 nucleotides long, derived from sequential RNase
III-dependent cleavages of longer transcripts [2,3]. In the
cytoplasm, mature miRNAs associate with components of the
RNA-induced Silencing Complex (RISC) and interact with
miRNA-recognition elements (MRE’s) in the 39 UTRs of target
mRNAs. Mismatches or gaps in the base-pairing interactions
between the miRNA-mRNA duplex result in translational
repression and/or mRNA de-stabilization [4,5]. In humans, it
has been estimated that the number of unique miRNAs exceeds
1000 [6] and that 20–30% of the transcriptome is subject to
miRNA-targeted regulation [7,8]. Although miRNAs target and
regulate specific mRNA transcripts via intracellular mechanisms,
recent evidence for their presence in vesicles circulating in the
blood of humans [9] raises the possibility that miRNAs may also
function as extracellular or secreted regulatory signals that mediate
communication between cells [10]. In accord with their role in
modulating the transcriptome and proteome, miRNAs play an
integral role in important biological processes like development,
metabolism and cancer biology.
Recent studies have also implicated miRNAs in the regulation
of the circadian timekeeping mechanism in the mammalian
suprachiasmatic nuclei (SCN). Brain, muscle ARNT-like protein 1
(Bmal1), circadian locomotor output cycles kaput (Clock), as well as
the Period (Per1 and Per2) and Cryptochrome (Cry) genes comprise
the ‘‘gears’’ of the molecular clockworks common to both the SCN
and peripheral tissues [11,12,13]. Interactions between these clock
components form positive- and negative-feedback loops in which
gene transcription is rhythmically regulated by their protein
products, with exception of Clock. For example, rhythmic increases
in Bmal1 transcription and the formation of CLOCK:BMAL1
heterodimers positively regulate the rhythmic transcription of the
Per and Cry genes [14]. In turn, the increases in PER and CRY
proteins lead to the formation of heterodimers that interact with
the CLOCK:BMAL1 complex and negatively feedback on their
own transcription. CLOCK:BMAL1 complexes also mediate the
regulation of clock-controlled outputs that provide for the
rhythmic programming of downstream processes. MiRNA func-
tion in SCN-mediated regulation of circadian rhythms is
supported by observations indicating that miR-219 and miR-132
are rhythmically expressed in the SCN and that antagonism of
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these miRNAs within the SCN region respectively increases the
circadian period of behavioral rhythmicity and attenuates
circadian photoentrainment [15]. Other applications of mouse,
Drosophila and chicken models provide further evidence for the role
of miRNAs in the regulation of circadian rhythms in gene
expression or behavior [16,17,18]. However, evidence for the role
of specific miRNAs as bona fide modulators of core clock genes is
limited.
Because rhythmicity is a prevalent property among core and
regulatory elements of the circadian clockworks in most cells and
tissues throughout the body, we explored the possible timekeeping
function of miRNAs in the periphery by initially determining
whether specific miRNAs with clock genes as predicted targets are
expressed in serum and whether their expression is marked by
daily fluctuations. Our analysis focused on miRNAs that are
predicted to target the 39 UTR of Bmal1 mRNA because this clock
gene is unique among core clock elements as knockout of Bmal1
alone produces complete loss of circadian rhythmicity [19].
Specifically, experiments were conducted to explore miRNA
function in the circadian clockworks by: 1) first identifying
miRNAs predicted to target core and ancillary clock genes; 2)
determining whether expression of specific miRNAs that target
Bmal1 oscillate in mouse serum in vivo; and 3) examining the effects
of candidate miRNA over-expression on Bmal1 39 UTR activity.
Materials and Methods
Experiment 1: Temporal Profiling of miRNA levels in
mouse serum
Animals. Experimental subjects were 20 male Balb/C mice
at 8–10 weeks of age. All animals were born and reared in the
animal facility at BIOO Scientific under a standard 12 h
light:12 h dark photoperiod (LD 12:12; lights-on at 0700 hr).
Prior to experimental analysis, animals were housed 2–3 per cage.
Access to food and water was provided ad libitum and periodic
animal care was performed at random times.
Ethics Statement. All animal procedures used in this study
were conducted in compliance with protocol B002 as approved by
the Institutional Animal Care and Use Committee at BIOO
Scientific Corp.
Blood collection and fractionation. To determine whether
miRNAs are expressed and fluctuate rhythmically in the serum,
blood samples were collected at 4 hour intervals from mice
maintained in a LD 12:12 cycle. At each timepoint, blood was
collected by cardiac puncture from 3–4 mice that were anesthetized
with 2,2,2-tribromoethanol (250 mg/kg, intraperitoneal; Sigma)
and sacrificed by cervical dislocation. Sampling procedures during
the dark phase of the LD 12:12 cycle (Zeitgeber Time [ZT] 12–24)
were conducted under dim red light (Kodak filter GBX-2). Blood
was allowed to clot at room temperature for 10–15 minutes.
Adhesions between the clot and collection tube were gently
detached by ‘‘rimming the clot’’ to minimize hemolysis and then
samples were centrifuged for 10 minutes in a swinging bucket
microcentrifuge (Eppendorf) at 3,0006 g to separate cellular and
non-cellular fractions. Immediately following centrifugation, the
serum layer was carefully aspirated off, mixed with three equivalent
volumes of TRI reagent (Ambion) and stored at220uC until further
processing.
To fractionate the white blood cells (WBCs), the clot was
disaggregated in phosphate buffered saline (PBS) and the fluid
layer containing suspended WBCs and red blood cells (RBCs) was
collected. Following centrifugation for 30 seconds at 3,0006g, the
cell pellet was resuspended in distilled water for ,10 sec to lyse
RBCs by osmotic shock, and then mixed with 106PBS to restore
physiological ionic strength and prevent WBC lysis. The WBC
pellet was recovered by centrifugation at 3,0006g for 40 sec, lysed
in 1 ml BiooPure RNA Isolation Reagent (BIOO Scientific,
Austin, TX) and stored at 220uC until further processing.
RNA extractions. Total RNA was subsequently extracted
from the serum and WBC lysates according to manufacturer’s
protocols, with the exception that 50 ug of linear acrylamide was
added as a co-precipitant to the aqueous phase before addition of
isopropanol. This modification enhances recovery of small
amounts of nucleic acids [20]. RNA samples were suspended in
50 ul 0.1 mM EDTA and dissolved by heating for 5 min at 65uC.
Total RNA was estimated using Nanodrop ND2000 (Thermo
Scientific).
Real-time PCR. Quantitative real-time PCR analysis was
conducted using Taqman microRNA assays (Applied Biosystems).
RNA from individual samples was first reverse transcribed using
target-specific stem-loop primers and Taqman MicroRNA
Reverse Transcription Kit. All assays were performed according
to manufacturer’s protocols, using 20 ng of total RNA as input
with the exception that 90 ng input RNA was used for reverse
transcription of miR-494. For analysis of miRNA expression, the
cDNA equivalent of 2 ng of total RNA was PCR amplified in an
ABI PRISM 7500 Fast sequence detection system using the
following standard conditions: 1) heating at 95uC for 10 min, and
2) amplification over 40 cycles at 95uC for 15 sec and 60uC for
1 min. This analysis was conducted concurrently on duplicate
aliquots of RT product from each sample. miR-16 was also
amplified from the same samples using identical parameters to
control for differences in sample RNA content and reverse-
transcription efficiencies because: 1) this miRNA has provided a
good standard for normalization and comparisons of relative
abundance in previous studies [21,22]; and 2) ANOVA analysis
indicates that miR-16 levels in the serum exhibit no significant
variation (p=0.19) over the 24-hour time course for sampling
(data not shown). Using the comparative CT method described in
the ABI Prism 7700 Sequence Detection System User Bulletin #2
(PE-ABI), the relative abundance for a given miRNA was
calculated by normalization first to corresponding miR-16 levels
in each sample and then to a calibrator consisting of pooled cDNA
from multiple samples over the entire time series. All TaqMan
miRNA assays used in this study exhibited PCR efficiencies of 95–
101.6% (Figure S1).
Relative quantification of 18s rRNA abundance was performed
on some serum and WBC samples using SYBR-Green real-time
PCR technology (ABI) as described previously [23,24]. To
generate single-strand cDNAs, total RNA (250 ng) from individual
samples was reverse transcribed using random hexamers and
Superscript III reverse transcriptase (Invitrogen). 18s rRNA was
PCR amplified using the cDNA equivalent of 2.5 ng of total RNA.
PCR analysis was performed on duplicate aliquots of each sample
using the ABI PRISM 7500 Fast sequence detection system and
the following conditions: 1) serial heating at 50uC for 2 min and
95uC for 10 min, 2) amplification over 40 cycles at 95uC for 15 sec
and 60uC for 1 min, and 3) dissociation at 95uC for 15 sec, 60uC
for 1 min, 95uC for 15 sec and 60uC for 15 sec. Relative
differences in 18s rRNA abundance were established by
comparing serum and WBC determinations to a standard curve
that was generated using pooled cDNA from all samples. The
following primers were used for the real-time PCR analysis: m18s
rRNA forward: 59-ATGGCCGTTCTTAGTTGGTG -39; m18s
rRNA reverse: 59-CGCTGAGCCAGTCAGTGTAG -39.
To estimate the number of copies of representative miRNAs in
serum samples, synthetic single-stranded RNA oligonucleotides
encoding the mature miRNA sequences for miR-16 and miR-152
MiRNA Profiles in Serum and Bmal1 39UTR Regulation
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were purchased from Integrated DNA Technologies, Inc. Mature
miRNA sequence information was procured from miRBASE
(release 16.0; Sept. 2010). These synthetic miRNAs were used in a
dilution series ranging from 1 molecule/ml to 1010 molecules/ml to
generate standard curves for quantification of molecules of miR-16
and miR-152. Standard curves derived from concentrations
yielding Ct values within the linear range were used to estimate
the number of copies of miR-16 and miR-152 in the input RNA
from ZT7 serum samples that were simultaneously reverse-
transcribed, PCR-amplified and analyzed on the same plate.
Absolute copy number of miRNAs per microliter of serum was
extrapolated using known information on the amount of input
RNA (10 ng) and total extracted RNA (1500–4500 ng) relative to
the specific volume collected (200–300 ml) for each serum sample.
Experiment 2: MiRNA regulation of Bmal1 39 UTR activity
mBmal139UTR luciferase reporter construct. miTargetTM
miRNA Target Sequence 39 UTR Expression Clone for Bmal1 was
purchased from Genecopoeia . This expression clone contains Bmal1
(Accession: NM_007489.3) 39 UTR sequence inserted in the pEZX-
MT01 vector downstream of a firefly luciferase gene under the
control of an SV40 enhancer generating a chimeric transcript that
consists of the luciferase coding and Bmal1 39UTR sequences (Figure
S2). The pEZX-MT01 vector also contains the Renilla luciferase gene
under the control of a CMV promoter to provide for dual analysis of
firefly and Renilla luciferase activities in individual samples and to
normalize firefly luciferase signal intensities and account for potential
differences in transfection efficiencies across control and
experimental cultures. To determine the specificity of miRNA
interactions with the Bmal1 39 UTR, similar analyses were
performed using miRNA 39 UTR target control vector
(Genecopoeia; CmiT000001-MT01), which consists of the
pEZX-MT01 vector without a 39 UTR tagged to the firefly
coding sequence. miTargetTM miRNA Target Sequence 39 UTR
Expression Clone encoding the cKit 39 UTR (Accession:
NM_021099.2; generously provided by Dr. Rajesh Miranda,
Texas A&M University Health Science Center) was also used as
an additional control. Based on the results from Targetscan
analysis, the cKit 39 UTR is predicted to contain a target site for
miR-494, but not for miR-142-3p or miR-152. The cKit 39 UTR
also contains a predicted target site for miR-142-5p, the antisense
transcript of miR-142-3p.
Transformed E. coli cells (Genecopoeia) were grown on
kanamycin (final conc. = 50 ug/ml) containing imMedia agar
plates (Invitrogen). A single isolated colony was propagated in
imMedia Kan+ (final conc. = 50 ug/ml) liquid medium and
plasmid was extracted using EndoFree Plasmid Maxi kit (Qiagen).
The extracted pEZX-MT01 Bmal1 39 UTR expression plasmid
was sequenced to verify expression and accuracy of the Bmal1 39
UTR sequence using the following primers: Forward: 59-
GATCCGCGAGATCCTGAT-39; Reverse: 59-TTGGCGTTA-
CTATGGGAACAT-39. Similar procedures were followed for
isolation of the pEZX-MT01 control vector and the pEZX-MT01
cKit 39 UTR expression vector.
Cell culture and transfections. Human embryonic kidney
cells (HEK293) at passage 12–15 were used for experimental
analysis of miRNA regulation of Bmal1 39 UTR activity. Cells
were seeded on 60-mm cell culture dishes (Corning) and
maintained at 37uC and 5% CO2 in Dulbecco’s minimum
essential medium (DMEM; Invitrogen) without antibiotics and
supplemented with 10% Fetal Bovine Serum (FBS; HyClone,
Logan, UT) and 292 ug/mL L-glutamine. Medium was changed
at 48-hour intervals and confluent cultures were split 1:4 or 1:5
every 3–4 days. Prior to experimentation, cells were seeded onto
24-well plates in DMEM supplemented with 5% FBS. 24 hours
later, co-transfection of verified plasmid DNA clones (0.4 ug) with
either individual pre-miRs, or paired combinations of pre-miR
constructs for miR-494, miR-152, or miR-142-3p (final conc.
33 nM/well; ABI) was performed using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocols. To
compare basal luciferase reporter activity across different pEZX-
MT01 vectors and evaluate the potential influence of endogenous
miRNAs, parallel analysis was performed on HEK293 cells in
which either the pEZX-MT01 control vector or the Bmal1 39
UTR vector was co-transfected with a non-targeting control
miRNA. Following incubation with transfection reagents for
5 hours, the medium was replaced and 48 hours later, lysates of
HEK293 cultures from all treatment groups (n = 4) were collected
using Passive Lysis Buffer (Promega). Lysate samples were stored
at 220uC and later firefly luciferase activity was analyzed relative
to Renilla luciferase activity in the same sample using dual-
luciferase reporter assay system (Promega). Luminescence was
measured in counts per second using a LumiCount microplate
luminometer (AL10000; Packard Bioscience).
Statistical analyses. The temporal patterns of miRNA
expression in serum were examined for evidence of circadian
variation using statistical analyses that have been used previously
for this purpose [23,25,26]. Time-dependent fluctuations in miR-
494, miR-152 and miR-142-3p expression were first identified by
one-way analysis of variance (ANOVA). Paired comparisons
between peak values and those observed during the preceding or
succeeding minimum were analyzed post hoc for statistical
differences using the Newman-Keuls sequential range test. The
a-value was set at 0.05 for these post hoc analyses.
Independent t-tests were performed on serum and WBC 18s
and miRNA comparisons, and on normalized luminescence data
to determine the significance of pre-miR and control-miR
treatment on luciferase-reported Bmal1 39 UTR activity. The a-
value was set at 0.01 for independent t-tests.
Results
Experiment 1: Temporal Profiling of miRNA levels in
mouse serum
Three target prediction databases (microcosm [27,28], Targets-
can [7] and MiRanda [29]) were used to identify potential
miRNAs targeting mammalian clock genes. Because Bmal1 is the
only clock gene in which null mutation produces arrhythmicity
[19], we focused on a subset of miRNAs that expresses consensus
recognition sequences for the 39 UTR of either Bmal1 or for other
genes that regulate Bmal1 expression in the molecular feedback
loops comprising the circadian clockworks (Table 1). The Bmal1 39
UTR was predicted to contain miR-152, miR-142-3p and miR-
494 target sites that are located at nucleotide positions 88–108,
335–357 and 473–495, respectively (Figure S3). It is interesting
that in addition to their putative targeting of the Bmal1 39 UTR,
miR-152 and miR-494 were also predicted to interact with its
primary partner Clock or with transcriptional activators, retinoic
acid-related orphan receptors alpha and beta (Rora, Rorb). We next
determined whether any of the identified miRNAs predicted to
target Bmal1 or other components of the clock feedback loops were
expressed in serum. All of the candidate miRNAs were detected in
serum during the daytime of LD 12:12 cycle (ZT 7), but their
circulating levels spanned a wide range. miR-142-3p, miR-152,
miR-494, miR-135b, miR-135a and miR-34c were found in
descending order of abundance in the serum (Fig. 1A). Consistent
with previous observations on its circulating levels in humans [9],
miR-16 was highly abundant relative to other miRNAs detected in
MiRNA Profiles in Serum and Bmal1 39UTR Regulation
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mouse serum. Quantitative analysis of miR-16 and miR-152 levels
revealed that the estimated concentrations of these miRNAs were
408,000–749,000 and 3,400–6,800 copies/ml serum (Fig. 1B),
respectively. Using this information as a relative index of
abundance, miR-142-3p, miR-152 and miR-494 appear to
represent species of moderate to low expression in serum. To
gauge the relationship between serum and cellular miRNA levels,
we also analyzed the WBC fractions of individual blood samples
for expression of specific miRNAs predicted to target Bmal1. These
components of blood exhibited variable differences in miRNA
levels such that miR-142-3p and miR-494 expression were lower
(77-fold and 1.5-fold, respectively) and miR-152 was higher (25-
fold) in serum than in WBCs (Fig. 2A). The differential expression
of miR-142-3p in WBCs is not surprising because this miRNA is
highly abundant in hematopoietic cell lineages [30].
Because recent findings indicate that despite their abundant
expression in the cytoplasm, 18s and 28s rRNA are absent in RNA
extracted from circulating exosomes [31], 18s rRNA levels were
analyzed in serum and WBC fractions of blood samples collected
from mice (n = 3–4) at ZT3 and ZT7 to confirm that the detected
small RNAs reflect serum expression, rather than artifact
associated with cellular lysis during sample preparation. Consistent
with the observations of Valadi et al. [31], serum levels of 18s
rRNA were negligible and at the limits of detection with real-time
Table 1. Application of target prediction programs to identify candidate miRNAs expected to target Bmal1 or other genes that
regulate Bmal1 expression.
mmu-miR-142-3p mmu-miR-152 mmu-miR-135b mmu-miR-135a mmu-miR-34c mmu-miR-494
MicroCosm Bmal1 Bmal1, Rorb - - Reverba Bmal1, Rorb
TargetScan Bmal1 - - - - Bmal1, Clock
MiRanda Bmal1 Bmal1, Rora, Rorb Rora, Rorb Rora, Rorb Per2 Bmal1, Per2, Rorb
doi:10.1371/journal.pone.0022586.t001
Figure 1. Comparison of circulating miRNAs predicted to target Bmal1 or other genes regulating Bmal1 expression with a highly
abundant miRNA in serum, miR-16. (A) Relative expression of miR-16, miR-142-3p, miR-152, miR-494, miR-135b, miR-135a and miR-34c in serum
samples collected from mice at ZT 7 (n = 3). Bars denote real-time PCR determinations of serum miRNA levels (mean 6 SEM) and the values are
plotted using a logarithmic scale in comparison with the average for miR-34c expression. (B) Quantification of miR-16 and miR-152 expression in
serum collected from mice at ZT 7 (n = 3). Symbols denote determinations (in duplicate) of the number of copies/ml serum in each sample that were
extrapolated by comparing the Ct values for experimental samples with standard curves consisting of a dilution series of known quantities of
synthetic miR-16 and miR-152 analyzed on the same plate.
doi:10.1371/journal.pone.0022586.g001
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PCR analysis. Relative expression levels of 18s rRNA in the serum
were 26,000–79,000-fold lower than those found in WBC fractions
(Fig. 2B), indicating that the observed miRNA signals in serum are
derived from extracellular or vesicle-encapsulated RNA, and not
from lysed or intact leukocytes or other cells, in the blood samples.
Daily profiles of miRNA expression in serum were assessed to
determine whether circulating levels of mature miRNAs that are
predicted to target mouse Bmal1 or other genes regulating this key
component of the molecular clockworks, miR-494, miR-152 and
miR-142-3p, oscillate rhythmically. In mice exposed to LD 12:12,
diurnal fluctuations were observed in the relative expression of
miR-494 and miR-152 (normalized to miR-16) in the serum
(Fig. 3). The rhythm in circulating levels of miR-494 was marked
by a bimodal pattern in which the first peak in serum expression
occurred around mid-day at ZT 7 and was followed by a
secondary peak during the night around ZT 19. For the diurnal
oscillation in miR-494 expression, the bimodal peaks in serum
levels at ZT 7 and ZT 19 were significantly (p,0.05) and about 2-
to 5-fold greater than those observed during the preceding and
succeeding minima. Similar to the temporal profile for miR-494
Figure 2. Comparison of miRNA and 18s rRNA levels in the serum and corresponding white blood cell (WBC) fractions. (A) Bars
denote real-time PCR determinations of serum and WBC miRNA levels (mean6 SEM) in blood samples collected from mice (n = 3) at ZT 7. The plotted
values correspond to the ratios of fraction-specific miR-142-3p, miR-494 and miR-152 signal and are represented as a percentage of the maximal value
obtained among the serum and WBC fractions. Asterisks denote comparisons in which the relative expression of miRNA signal in the WBC fraction
was significantly different (p,0.05) from that observed in serum samples. (B) Bars denote real-time PCR determinations of 18s rRNA levels (mean 6
SEM) in serum and WBC fractions of blood samples collected from mice (n = 3–4) at ZT 3 and ZT 7. The plotted values are represented as a percentage
of the average for the WBC fraction at ZT 7. Asterisks denote time-specific comparisons (ZT 3 and ZT 7) of 18s rRNA signal in which relative expression
in the WBC group was significantly greater (p,0.01) than that observed in serum samples.
doi:10.1371/journal.pone.0022586.g002
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expression, serum levels of miR-152 were characterized by diurnal
variation with bimodal peaks (Fig. 3). The first zenith in miR-152
expression occurred again at ZT 7 and was followed by a
secondary peak in mature miRNA levels at ZT 15. The amplitude
of rhythmic miR-152 expression in the serum was robust, with 2-
to 8-fold differences between peak and trough values. The bimodal
peaks in circulating levels of miR-152 at ZT7 and ZT15 were
significantly greater (p,0.05) than the preceding and succeeding
minima. In contrast to other tested miRNAs, miR-142-3p levels in
the serum exhibited no evidence of diurnal fluctuations (Fig. 3). In
comparison with miR-494 and miR-152, serum levels of miR-142-
3p were relatively high with no significant variation over time
(p=0.377).
Experiment 2: MiRNA regulation of Bmal1 39 UTR activity
Since the observed circadian fluctuations in serum levels of
miRNAs predicted to target Bmal1 is suggestive of their
involvement in circadian timekeeping mechanisms, we used an
in vitro reporter assay to examine the effects of miR-494, miR-
152 and even miR-142-3p on Bmal1 expression via targeting of
the 39 UTR of this clock gene. Bioluminescence was analyzed in
HEK293 cells co-transfected with the pEZX-MT01 Bmal1 39
UTR expression vector and pre-miR constructs for miR-494,
miR-152, or miR-142-3p (n = 4). To control for non-specific
interactions between pre-miRs and the luciferase reporter in the
pEZX-MT01 vector, parallel analysis was performed on
HEK293 cells co-transfected with these pre-miR constructs
and the pEZX-MT01 control vector which does not contain a
39 UTR tagged to the firefly coding sequence (n = 4). In
HEK293 cells co-transfected with Bmal1 39 UTR expression
vector, over-expression of miR-494 or miR-142-3p, but not
miR-152, produced significant decreases (p,0.01) in luciferase-
mediated bioluminescence relative to that found in cells
transfected with the control vector (Fig. 4A). Treatment with
pre-miR constructs for miR-494 or miR-142-3p repressed Bmal1
39 UTR-mediated bioluminescence by about 35% and 60%,
respectively, in comparison with control transfections. Trans-
fection with a non-targeting miRNA had no significant effect on
luciferase-mediated bioluminescence in Bmal1 39 UTR-express-
ing cells relative to that found in cells transfected with the
control vector, suggesting that basal reporter activity is similar
between the Bmal1 39 UTR and control vectors and that the
observed repression of the Bmal1 39 UTR is specific for miR-494
and miR-142-3p.
Figure 3. Temporal patterns of miR-494, miR-152 and miR-142-3p expression in mouse serum. Symbols denote real-time PCR
determinations of miRNA levels (mean 6 SEM) in serum collected at 4-hour intervals from mice (n = 3–4) during exposure to a LD 12:12 cycle. The
plotted values correspond to the ratios of miR-494 (top left), miR-152 (top right) and miR-142-3p (bottom) signal normalized to miR-16 levels in each
sample and are represented as a percentage of the maximal value obtained for each miRNA. Asterisks indicate time points during which peak values
for serum expression of a given miRNA were significantly greater (p,0.05) than those observed during preceding and succeeding minima.
doi:10.1371/journal.pone.0022586.g003
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Pre-miR interactions with the 39 UTR of a non-clock gene
containing predicted target sites for miR-494 but not miR-152 or
miR-142-3p were explored by analyzing bioluminescence from
HEK293 cells co-transfected with the pEZX-MT01 vector
expressing the cKit 39 UTR and pre-miR constructs for these
miRNAs (n= 4). Consistent with target prediction data indicating
that the cKit 39 UTR contains a predicted target site for miR-494,
overexpression of miR-494 in pEZX-MT01 cKit 39 UTR-
transfected cells yielded a significant reduction (p,0.01) in
luciferase-reported bioluminescence relative to that observed in
cells co-transfected with this pre-miR and the control vector
(Fig. 4A). In response to treatment with pre-miR constructs for miR-
494, cKit 39 UTR-mediated bioluminescence was repressed by
about 30% in comparison with luciferase reporter expression in cells
co-transfected with the control vector. Importantly, treatment with
pre-miR constructs for miR-152 had no significant effect in
repressing luciferase-mediated bioluminescence in cKit 39 UTR-
expressing cells. In fact, overexpression of miR-152 in pEZX-MT01
cKit 39 UTR-transfected cells produced a small increase in
bioluminescence relative to that found in control vector-transfected
cells. Interestingly, treatment with pre-miR constructs for miR-142-
3p caused a significant increase in cKit 39 UTR-mediated
bioluminescence relative to the luciferase activity of the control
vector. The basis for this inductive effect of miR-142-3p on cKit 39
UTR activity is unknown, but the cKit 39 UTR is predicted to
contain a target site for miR-142-5p and overexpression of its
antisense transcript, miR-142-3p, may effectively reverse any basal
repression derived from interactions of endogenous miR-142-5p
with the cKit 39 UTR.
Because previous studies indicate that two different miRNAs
can act in concert to simultaneously repress translation of a single
mRNA [32], we next examined the combinatorial effects of miR-
494, miR-152 and miR-142-3p overexpression in repressing Bmal1
39 UTR activity. For all of the tested miRNA combinations (miR-
494+miR-152, miR-494+miR-142-3p, miR-152+miR-142-3p),
luciferase-reported bioluminescence was significantly reduced
Figure 4. Independent and combinatorial effects of miR-494, miR-152 and miR-142-3p over-expression on Bmal1 39 UTR activity.
Bars denote mean (6SEM) determinations of luciferase bioluminescence for each treatment group (n = 4). The plotted values correspond to the ratios
of firefly luciferase signal normalized to Renilla luciferase activity in the same sample and are represented as a percentage of the average signal for
control vector transfectants. (A) Normalized bioluminescence from HEK293 cells expressing the pEZX-MT01 control vector, or pEZX-MT01 vector
containing either cKit 39 UTR or Bmal1 39 UTR in response to treatment with pre-miR constructs (33 nM) for miR-494, miR-152 and miR-142-3p. (B)
Normalized bioluminescence from HEK293 cells expressing the pEZX-MT01 control vector or pEZX-MT01 vector containing the Bmal1 39 UTR in
response to treatment with paired combinations of these pre-miR constructs (33 nM; miR-494+miR-152, miR-494+miR-142-3p, miR-152+miR-142-3p).
doi:10.1371/journal.pone.0022586.g004
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(p,0.01) in Bmal1 39 UTR-expressing cells relative to that control
vector transfectants (Fig. 4B). Combinatorial effects in repressing
luciferase-reported Bmal1 39 UTR activity were lowest in response
to miR-494 and miR-152 overexpression (,21%) and were
highest in cells treated with pre-miR constructs for miR-494 and
miR-142-3p (,75%). In conjunction with the observed differences
in the repressive effects of individual miRNAs, these results suggest
that among the tested transcripts, miR-142-3p is the most potent
repressor of Bmal1 39UTR-mediated activity. Moreover, the
potentiated repression observed in response to combined treat-
ment with pre-miR constructs for miR-142-3p and miR-494 is
compatible with previous evidence for the synergistic regulation of
the 39 UTR for a single gene by two or more miRNA species [32].
Based on the independent and combinatorial effects of miR-494
on Bmal1 39 UTR activity, our results support the possibility that
oscillations in serum levels of this miRNA may contribute to local
rhythms in the post-transcriptional repression of endogenous
Bmal1 in the periphery.
Discussion
Circulating levels of many humoral factors, including insulin,
adrenalin, leptin, ghrelin and corticosterol, are marked by
robust circadian rhythmicity [33,34]. These hormones and
neuroendocrine factors are thought to play a role in the
hierarchical organization of the mammalian circadian system
with regard to the coordination of rhythmicity between
peripheral and CNS oscillators [35,36]. Although there is now
increasing evidence for the presence of circulating miRNAs and
their potential implications as biomarkers of pathological and
physiological states [9,37,38], the current study provides
primary evidence indicating that levels of some circulating
miRNA species are subject to rhythmic regulation as well.
Specifically, our findings indicate that several miRNAs predict-
ed to target core clock genes are also expressed in mouse serum,
and that circulating levels of miR-494 and miR-152 are
distinguished by diurnal oscillations. Similar to other diurnal
and circadian rhythms in various processes, including arterial
pressure, neurotransmitter receptors, and circulating levels of
hormones [39,40,41], serum levels of miR-494 and miR-152
oscillate with bimodal patterns that are thought to reflect the
independent rhythmicity of two uncoupled oscillators. It is
noteworthy that despite the similarity in the phase of their
rhythmic profiles with bimodal peaks occurring near mid-day
and during the night, miR-494 and miR-152 are transcribed at
different loci in the mouse genome; both are transcribed from a
single locus, on chromosome 11 for miR-152 and on
chromosome 12 for miR-494. Another distinction is that miR-
152 is an intronic miRNA, while miR-494 is part of a large
cluster.
The mechanism responsible for the rhythmic variations in
serum levels of miR-494 and miR-152 is unknown. Importantly,
comparative analysis of 18s rRNA levels in serum and corre-
sponding WBC samples suggests that the miRNA expression and
rhythmic profiles detected in serum are not contamination or
artifact derived from lysed or intact cells in the circulation. The
observed rhythms in circulating levels of miR-494 and miR-152
may correspond to temporal variation in the intracellular
production, packaging or endocytic trafficking of these miRNAs
and/or their uptake by specific target cells. Alternatively, it is
possible that the differential stability of some circulating miRNAs
over time may contribute to these serum oscillations.
Recent evidence suggests that miRNAs may act as molecular
switches regulating the timing of various biological events [42].
Thus, the present implications for miRNAs in circadian
timekeeping seem to represent a logical extension of their known
functions. At present, the precise role of miRNAs in either the
molecular clockworks or the hierarchical organization of
mammalian circadian oscillators is unclear. Several reports
indicate that miRNAs may modulate some aspects of circadian
pacemaker function and output rhythms [15,16]. Using in vitro
analysis of luciferase-reported Bmal1 39 UTR activity to examine
the effects of miRNA over-expression, miR-494 and miR-142-3p
were identified as potential post-transcriptional repressors of
Bmal1, for the first time implicating specific miRNAs in the
regulation of this integral molecular component of the mamma-
lian circadian clock.
The phase relationship between the diurnal rhythms in
circulating levels of these miRNAs and Bmal1 oscillations in the
periphery is consistent with the potential function of miR-494 in
the post-transcriptional regulation of Bmal1. In most peripheral
tissues, Bmal1 accumulation follows a circadian profile in which
mRNA levels are high from the middle of the night to early
morning and remain low throughout the rest of the cycle
[43,44]. Hepatic BMAL1 protein content oscillates in a similar
fashion such that the rhythmic peak occurs late in the subjective
night and levels rapidly decline near the middle of the subjective
day [45]. Thus, the observed oscillations in circulating levels of
miR-494 and miR-152 exhibit an interesting relationship with
reported circadian profiles for Bmal1 in the periphery, with
bimodal peaks of miRNA expression encompassing times
around the rising and falling phases of the Bmal1 mRNA as
well as protein rhythms. In conjunction with our evidence for
miR-494-mediated repression of the Bmal1 39 UTR, the
bimodal pattern of these serum oscillations may have some
significance for the function of miR-494 and other miRNAs
regulating core clock components as local and/or systemic cues
that fine-tune the circadian harmonics of intercellular interac-
tions and coordinate rhythmicity between autonomous circadi-
an oscillators in peripheral tissues.
Although both miR-494 and miR-142-3p target the same
gene, Bmal1, overt rhythmicity in extracellular levels may not be
the sole criterion determining their role in the mammalian
circadian system. Given the abundance of RNases in serum and
evidence for the rapid degradation of naked synthetic miRNAs
in plasma [9,46], it seems likely that the endogenous serum
miRNAs observed in our experiments are packaged within
various types of protective, membrane-bound particles, such as
microvesicles and exosomes. Vesicles released into the circula-
tion in vivo presumably arise from a wide variety of cells derived
from different lineages and subtypes at different stages of
maturation, and are distinguished by diverse functions. Recent
studies indicate that these secreted vesicles mediate the
intercellular communication of specific RNA signals
[31,47,48,49] and that vesicle-transmitted miRNAs are func-
tional in recipient cells [47,48]. Furthermore, different miRNAs
are packaged in vesicles and exosomes expressing integral cell
membrane proteins derived from their parental cells of origin,
and these cell surface markers appear to specify the capture of
these particles by certain tissues or cell types. For example,
mature dendritic cell derived exosomes that express intercellular
adhesion molecule-1 (ICAM1) are captured largely by lympho-
cyte function-associated antigen-1 (LFA-1) expressing activated
T-cells and CD8+ dendritic cells, but not by CD82 dendritic
cells [50,51]. Hence, the distinctive functions of different
circulating miRNAs in regulating the molecular clockworks or
overt circadian rhythms within or between specific tissues may
be determined not only by temporal variation in extracel-
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lular levels but also by the parental cells from which the
miRNA-containing vesicles originate, and by cell-surface
receptors on specific target cells that capture these circulating
vesicles.
Because a number of processes are subject to circadian
regulation in the cardiovascular system, circulating miRNAs
may play an important role in the local and/or systemic
coordination of circadian rhythms associated with cardiovascular
physiology and pathology. The cardiovascular system is distinctly
characterized by circadian regulation of various parameters such
as arterial pressure, heart rate, and vascular tone [52,53].
Furthermore, circadian variation is an important factor in the
manifestation of cardiovascular pathology, including myocardial
infarction, sudden cardiac death and stroke [52]. The role of
identified miRNAs with Bmal1 as a putative target and rhythmic
variations in their circulating levels in cardiovascular physiology
and disease is currently unknown. However, miR-494 has been
recently implicated in cardiac pathophysiological processes
because cardiac-specific over-expression of this miRNA reduces
myocardial infarction size in response to ischemia/reperfusion-
induced cardiac injury [54]. In addition, the recent finding that
deletion of several secretory vesicle proteins disrupts circadian
rhythms of blood pressure and heart rate in the mouse [55] may
have further implications for the role of extracellular miRNAs in
regulating cardiovascular physiology. Nevertheless, our results
suggest that extracellular miRNAs may play a role in the
regulation of peripheral circadian clocks and that circadian
profiling and comparison of different serum miRNAs in various
disease models may provide a valuable tool in identifying
biomarkers for human cardiovascular pathologies associated with
circadian rhythm disturbances.
Supporting Information
Figure S1 Estimation of qPCR efficiencies for Taqman
miRNA assays. qPCR efficiencies were calculated using the
formula; E= 10(21/slope of standard curve). Percentage efficiencies
were calculated using the formula; %E= (E21)6100. For miR-16
and miR-152 assays (A), ‘E’ was calculated based on the slopes of
standard curves generated using synthetic single-stranded RNA
oligonucleotides. For miR-142-3p and miR-494 assays (B), the
slopes of standard curves generated using dilutions of a calibrator
created from pooled cDNA samples from various timepoints were
used to calculate ‘E’.
(TIF)
Figure S2 Design of pEZX-MT01 Bmal1 and cKit 39 UTR
luciferase reporter vectors. pEZX-MT01 dual luciferase
reporter plasmid construct encodes a chimeric transcript
containing the mouse Bmal1 or cKit 39 UTR tagged to firefly
luciferase coding sequence under control of an SV40 enhancer.
In comparison, the miRNA 39 UTR target control vector lacks a
39 UTR target downstream of the pEZX-MT01 firefly luciferase
coding sequence. All vectors contain a kanamycin resistance
cassette for selection of bacterial transformants stably expressing
the pEZX-MT01 plasmid and the Renilla luciferase coding
sequence transcribed under control of CMV promoter to
normalize firefly luciferase signal intensities across samples.
(TIF)
Figure S3 Predicted interactions between miR-494,
miR-152 and miR-142-3p and the Bmal1 39 UTR.
Diagrammatic representation of predicted interactions betweenmature
(A) miR-494, (B) miR-152 and (C) miR-142-3p with complementary
regions of the wild-type Bmal1 39UTR. Dotted lines indicate potential
stabilizing interactions between guanine and thymine bases.
(TIF)
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